InvestorsHub Logo
Followers 3352
Posts 85269
Boards Moderated 5
Alias Born 10/05/2005

Re: None

Friday, 03/20/2020 4:45:06 PM

Friday, March 20, 2020 4:45:06 PM

Post# of 8339
TNXP Is Rocketing On Data Anticipation
In the SEC filing the company said that it will present information with regard to TNX-1800. The candidate is being developed as a potential COVID-19 vaccine.

TNX-1800 was developed based on the company’s horsepox vector platform. The presentation will take place at the World Health Organization, or WHO, on March 20, 2020. TNXP said that the presentation may include nonpulic information and is filed as Exibit 99.01 with the SEC.

Give Me A Follow If You Want To Consistently Find Winners!

Click Here:
https://investorshub.advfn.com/boards/profilea.aspx?user=61470

Please do your own DD...All my posts are my opinion only!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TNXP News